Dental devices include products used for diagnosis of dental ailments and for dental treatment such as oral prophylaxis, dental surgical and restorative procedures. Dental membranes are used to prevent gum from growing into the bone cavity, and consist of non-resorbable membranes and resorbable membranes. GlobalData uses proprietary data and analytics to provide a comprehensive report on the dental membranes market in New Zealand. Buy the latest report here.

In 2022, GlobalData’s Market Model methodology determined that the leading player in the dental membranes market in New Zealand was Dentsply Sirona followed by Geistlich Pharma, Integra LifeSciences, Osteogenics Biomedical, Straumann and Zimmer Biomet.

Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.

A Dental membrane is placed over the bone but under the gum. Non-resorbable membranes, also known as non-dissolvable membranes, form a barrier that cannot be dissolved by saliva. Resorbable membranes, also known as dissolvable membranes are made from materials such as collagen (porcine or bovine derived), laminar bone, connective tissue transplants as well as resorbable synthetic membranes.

The dental membranes market in New Zealand can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.

For the latest analysis of the market size dental membranes in New Zealand, buy the report here.

This content was updated on 27 July 2024

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.